The invention provides novel compounds having the general formula:
and tautomers and pharmaceutically acceptable salts thereof, wherein A
1
, A
2
, A
3
, A
4
, R
1
, R
4
, R
5
, R
6
, R
7
and R
8
are as defined herein, compositions including the compounds and methods of using the compounds.
BIARYLMETHYL HETEROCYCLES
申请人:Universite de Montreal
公开号:US20190202808A1
公开(公告)日:2019-07-04
The present invention provides compounds of Formula (I):
wherein all variables are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are biased agonists, or β-Arrestin agonists of the angiotensin II receptor, which may be used as medicaments.
Nitrogen-containing Heterocyclic Compound and Composition Thereof, Preparation Method Therefor, and Application Thereof
申请人:SHANGHAI PHARMACEUTICALS HOLDING CO., LTD.
公开号:US20220048915A1
公开(公告)日:2022-02-17
Disclosed by the present invention are a nitrogen-containing heterocyclic compound, and a composition thereof, a preparation method therefor and an application thereof. The structure of the nitrogen-containing heterocyclic compound according to the present invention is shown in Formula I. The nitrogen-containing heterocyclic compound according to the present invention or a pharmaceutically acceptable salt thereof has better inhibitory activity on p38 protein kinase and/or higher bioavailability. In addition, the preparation method is simple.